Cowen Reiterates Outperform Rating on NuVasive (NUVA) After Conference Presentation
Tweet Send to a Friend
Cowen analyst Joshua Jennings reiterated an Outperform rating and $65.00 price target on NuVasive (NASDAQ: NUVA) after the CEO, Chris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
